Literature DB >> 182508

The potentiating effects of 4-aminopyridine on adrenergic transmission in the rabbit vas deferens.

A Johns, D S Golko, P A Lauzon, D M Paton.   

Abstract

The effects of 4-aminipyridine on adrenergic transmission in rabbit vas deferens were investigated. 10(-5)-10(-3) M 4-aminopyridine markedly potentiated the sustained, secondary contractile response to transmural stimulation and significantly increased the amount of (+/-)-|3H]-metaraminol released at 5 Hz, but had little effect on responses to exogenous (-)-noradrenaline. 10(-5)-10(-4) M 4-aminopyridine did not significantly alter the accumulation or efflux of (-)-[3H]-noradrenaline in rabbit heart. It is suggested that 4-aminopyridine potentiated responses of rabbit vas deferens to transmural stimulation mainly by increasing transmitter release, possibly as a result of prolongation of the action potential. Responses to transmural stimulation were also potentiated by by 2- and 3-aminopyridine and by 3,4-diaminopyridine but not by pyridine, aniline, 4-dimethylaminopyridine, 4-aminoethylpyridine or 2-aminopyrimidine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182508     DOI: 10.1016/0014-2999(76)90202-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  4-Aminopyridine antagonizes the inhibitory effect of pentobarbital on acetylcholine release in the heart.

Authors:  W Weide; K Löffelholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

2.  Positive inotropic effect of 4-aminopyridine on dog ventricular muscle.

Authors:  T Yanagisawa; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

3.  3,4-diaminopyridine. A potent new potassium channel blocker.

Authors:  G E Kirsch; T Narahashi
Journal:  Biophys J       Date:  1978-06       Impact factor: 4.033

4.  Differential effects of Ca antagonists on the noradrenaline release and contraction evoked by nerve stimulation in the presence of 4-aminopyridine.

Authors:  H Kato; Y Takata
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

5.  Effect of 4-aminopyridine on cardiovascular functions in the dog.

Authors:  E Martínez-Aguirre; J A Wikinski; A Bello; J Izquierdo; A Garcia; H Velarde
Journal:  Can Anaesth Soc J       Date:  1981-03

6.  The actions of aminopyridines on avian muscle.

Authors:  W C Bowman; A L Harvey; I G Marshall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

7.  Effective treatment of verapamil intoxication with 4-aminopyridine in the cat.

Authors:  S Agoston; E Maestrone; E J van Hezik; J M Ket; M C Houwertjes; D R Uges
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

8.  Effects of cyclopiazonic acid on contractility and ecto-ATPase activity in guinea-pig urinary bladder and vas deferens.

Authors:  A U Ziganshin; C H Hoyle; L E Ziganshina; G Burnstock
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

9.  Comparative study of the effects of 4-aminopyridine and tetraethylammonium on neuro-effector transmission in the guinea-pig vas deferens.

Authors:  Y Ito; S Korenaga; K Tajima
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

10.  Effects of 4-aminopyridine on the turnover of monoamines in the central nervous system of the rat.

Authors:  N E Andén; S Leander
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.